ABSCI CORP Interest Expense
ABSCI CORP (ABSI) reported Interest Expense of $176.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-14
- ABSCI CORP interest expense for the quarter ending 2024-03-31 was $176.00K, a 45.17% decline year-over-year.
- ABSCI CORP interest expense for the quarter ending 2023-12-31 was $204.00K, a 28.92% decline year-over-year.
- ABSCI CORP interest expense for the quarter ending 2023-09-30 was $229.00K, a 17.92% decline year-over-year.
- ABSCI CORP interest expense for the quarter ending 2023-06-30 was $256.00K, a 21.33% increase year-over-year.
- ABSCI CORP interest expense for fiscal 2023 was $1.01M, a 3.91% increase from fiscal 2022.
- ABSCI CORP interest expense for fiscal 2022 was $972.00K, a 71.68% decline from fiscal 2021.
- ABSCI CORP interest expense for fiscal 2021 was $3.43M, a 441.32% increase from fiscal 2020.
- ABSCI CORP interest expense for fiscal 2020 was $634.00K.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-03-31 | $176.00K 10-Q · filed 2024-05-14 | $380.00K derived: sum of 2 quarters · filed 2024-05-14 | $609.00K derived: sum of 3 quarters · filed 2024-05-14 | $865.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-12-31 | $204.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $433.00K derived: sum of 2 quarters · filed 2024-03-21 | $689.00K derived: sum of 3 quarters · filed 2024-03-21 | $1.01M 10-K · filed 2024-03-21 |
| 2023-09-30 | $229.00K 10-Q · filed 2023-11-14 | $485.00K derived: sum of 2 quarters · filed 2023-11-14 | $806.00K 10-Q · filed 2023-11-14 | $1.09M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-06-30 | $256.00K 10-Q · filed 2023-08-14 | $577.00K 10-Q · filed 2023-08-14 | $864.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.14M derived: sum of 4 quarters · filed 2024-05-14 |
| 2023-03-31 | $321.00K 10-Q · filed 2024-05-14 | $608.00K derived: sum of 2 quarters · filed 2024-05-14 | $887.00K derived: sum of 3 quarters · filed 2024-05-14 | $1.10M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $566.00K derived: sum of 2 quarters · filed 2024-03-21 | $777.00K derived: sum of 3 quarters · filed 2024-03-21 | $972.00K 10-K · filed 2024-03-21 |
| 2022-09-30 | $279.00K 10-Q · filed 2023-11-14 | $490.00K derived: sum of 2 quarters · filed 2023-11-14 | $685.00K 10-Q · filed 2023-11-14 | $885.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $211.00K 10-Q · filed 2023-08-14 | $406.00K 10-Q · filed 2023-08-14 | $606.00K derived: sum of 3 quarters · filed 2023-08-14 | $1.37M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $195.00K 10-Q · filed 2023-05-15 | $395.00K derived: sum of 2 quarters · filed 2023-05-15 | $1.16M derived: sum of 3 quarters · filed 2023-05-15 | $3.17M derived: sum of 4 quarters · filed 2023-05-15 |
| 2021-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $968.00K derived: sum of 2 quarters · filed 2023-03-30 | $2.98M derived: sum of 3 quarters · filed 2023-03-30 | $3.43M 10-K · filed 2023-03-30 |
| 2021-09-30 | $768.00K 10-Q · filed 2022-11-09 | $2.78M derived: sum of 2 quarters · filed 2022-11-09 | $3.23M 10-Q · filed 2022-11-09 | $3.41M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $2.01M 10-Q · filed 2022-08-11 | $2.46M 10-Q · filed 2022-08-11 | $2.64M derived: sum of 3 quarters · filed 2022-08-11 | $2.81M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $455.00K 10-Q · filed 2022-05-11 | $630.00K derived: sum of 2 quarters · filed 2022-05-11 | $802.00K derived: sum of 3 quarters · filed 2022-05-11 | $991.00K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $347.00K derived: sum of 2 quarters · filed 2022-03-22 | $536.00K derived: sum of 3 quarters · filed 2022-03-22 | $634.00K 10-K · filed 2022-03-22 |
| 2020-09-30 | $172.00K 10-Q · filed 2021-11-09 | $361.00K derived: sum of 2 quarters · filed 2021-11-09 | $459.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $189.00K 10-Q · filed 2021-09-07 | $287.00K 10-Q · filed 2021-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |